In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2.
Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More